Skip to main content
James Kim, MD, Oncology, Dallas, TX

JamesKimMDPhD

Oncology Dallas, TX

Thoracic Cancer

Assistant Professor, Division of Hematology-Oncology, Dept. of Internal Medicine, University of Texas Southwestern

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

  • Office

    5323 Harry Hines Blvd
    Dallas, TX 75390
    Phone+1 240-566-1616

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2002 - 2006
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1999 - 2002
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - Present
  • HI State Medical License
    HI State Medical License 2021 - 2026
  • MD State Medical License
    MD State Medical License 2012 - 2022
  • TX State Medical License
    TX State Medical License 2013 - 2018
  • GA State Medical License
    GA State Medical License 2011 - 2013
  • DC State Medical License
    DC State Medical License 2007 - 2008
  • American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

Press Mentions

  • The Hexosamine Biosynthesis Pathway Is a Targetable Liability in KRAS/LKB1 Mutant Lung Cancer
    The Hexosamine Biosynthesis Pathway Is a Targetable Liability in KRAS/LKB1 Mutant Lung CancerNovember 30th, 2020
  • Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects Nonsmokers
    Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017